{
  "id": "64179139690f196b5100002f",
  "type": "list",
  "question": "What are the most commonly used diagnostic tests for the diagnosis of Duchenne muscular dystrophy?",
  "ideal_answer": "The most commonly used diagnostic tests for the diagnosis of Duchenne muscular dystrophy include genetic testing, electromyography (EMG), muscle biopsy, and serum creatine kinase (CK) levels.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26037351",
    "http://www.ncbi.nlm.nih.gov/pubmed/30453357",
    "http://www.ncbi.nlm.nih.gov/pubmed/33734897",
    "http://www.ncbi.nlm.nih.gov/pubmed/35218518",
    "http://www.ncbi.nlm.nih.gov/pubmed/35929940",
    "http://www.ncbi.nlm.nih.gov/pubmed/36281417",
    "http://www.ncbi.nlm.nih.gov/pubmed/34327855",
    "http://www.ncbi.nlm.nih.gov/pubmed/24300647",
    "http://www.ncbi.nlm.nih.gov/pubmed/25271841",
    "http://www.ncbi.nlm.nih.gov/pubmed/33552634",
    "http://www.ncbi.nlm.nih.gov/pubmed/2669113",
    "http://www.ncbi.nlm.nih.gov/pubmed/23381834",
    "http://www.ncbi.nlm.nih.gov/pubmed/12022080",
    "http://www.ncbi.nlm.nih.gov/pubmed/8745379",
    "http://www.ncbi.nlm.nih.gov/pubmed/35359537"
  ],
  "snippets": [
    {
      "text": "Whole-exome sequencing was utilized to detect disease-causing variants in 40 MLPA-negative DMD patients. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35218518",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "WES analysis revealed that nonsense variant was the most common type in our study (23/36 of the cases).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35218518",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": ". The present study has demonstrated the importance of performing WES to detect disease-causing point mutations in MLPA-negative DMD patients and to identify carrier females.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35218518",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Whole exome sequencing (WES) and multiple ligation-dependent probe amplification (MLPA) were used to detect potential deletions in the STS and DMD genes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35929940",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The newborns with retest positive result were recalled again for serum creatine kinase (CK) and multiplex ligation-dependent probe amplification (MLPA) test.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36281417",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Whole exon sequencing was performed when MLPA test was negative.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36281417",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " In this study we aimed to determine the mutational spectrum of multiplex ligation-dependent probe amplification (MLPA)-negative muscular dystrophy patients in Pakistan using whole-exome sequencing. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33734897",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Whole-exome sequencing identified a nonsense variant in Pakistani muscular dystrophy patients, which is amenable to treatment by Ataluren ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33734897",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " We used the combination of multiplex ligation-dependent probe amplification (MLPA) and sequencing analysis of the DMD gene. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34327855",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We performed DNA tests in 152 patients, checking first exon deletion/duplication by MLPA, and subsequently, if negative, samples were sequenced to detect point mutations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34327855",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The strategy for molecular diagnostic testing for DMD involves initial screening for deletions/duplications using microarray-based comparative genomic hybridization (array-CGH) followed by full-sequence analysis of DMD for sequence variants.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25271841",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thus, NGS-based multigene panel testing for muscular dystrophy-associated genes or clinical exome sequencing rather than targeted DMD gene sequencing appears to be a more cost-effective testing modality with better diagnostic yield, for MLPA-negative patients with the DMD phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33552634",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To optimize the methods for genetic detection and prenatal diagnosis of Duchenne muscular dystrophy (DMD).METHODS: Denaturing high-performance liquid chromatography (DHPLC), multiplex PCR (mPCR), sequencing and other molecular techniques were used in combination for molecular diagnosis of 8 cases diagnosed as DMD.RESULTS: Among the 8 cases, 4 have carried large deletions, 3 have point mutations, among ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26037351",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Genetic testing for Duchenne/Becker muscular dystrophy (DMD/BMD) mutations initially involved multiplex polymerase chain reaction (mPCR), which targeted two mutation hotspots in the gene and detected deletions in aff",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24300647",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Most frequently performed first step diagnostic tests in Group I and Group II were muscle biopsy and MLPA.Our study reflects the change in the age at genetic diagnosis and diagnostic approach to nm-DMD depending on the advances and availability of genetic testing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30453357",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Dystrophin testing in muscle is the most sensitive test for identification of dystrophinopathy patients, although gene deletion studies can make the diagnosis in most cases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8745379",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnostic use of Xp21 probes is now as necessary as EMG, muscle biopsy and serum CK assay for the definition of Duchenne muscular dystrophy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2669113",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "MLPA, Multiple Ligation-Dependent Probe Amplification, WES, Whole-Exome Sequencing, target-NGS, Next Generation Sequencing, NGS"
}